2021年最新SCI期刊影响因子查询系统
Expert Opinion on Drug Delivery 期刊详细信息
基本信息
期刊名称 | Expert Opinion on Drug Delivery Expert Opinion on Drug Delivery |
---|---|
期刊ISSN | 1742-5247 |
期刊官方网站 | http://www.tandfonline.com/loi/iedd20 |
是否OA | 否 |
出版商 | Taylor and Francis Ltd. |
出版周期 | Bimonthly |
始发年份 | 2004 |
年文章数 | 90 |
最新影响因子 | 8.129(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | PHARMACOLOGY & PHARMACY 药学2区 | 否 | 是 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 5.13 | 1.337 | 1.297 |
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
8 / 164 | 95% |
补充信息
自引率 | 2.70% |
---|---|
H-index | 75 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1742-5247%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mc.manuscriptcentral.com/eodd |
---|---|
收稿范围 | Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering delivery technologies, vehicles and devices; nanotechnology; novel formulations; the delivery of specific drug and therapeutic classes; gene/vaccine delivery strategies; modes of entry into the body and applications in certain diseases and disorders Technology Evaluations reviewing a particular drug delivery technology Original Research Contributions are welcomed in the form of: - Delivery technologies, vehicles, formulations and devices - The delivery of specific drugs and therapeutic classes - Modes of entry into the body and applications in certain diseases and disorders Editorials commenting on the various drug delivery strategies which have been, and are being, explored Guidelines on the application of specific drug delivery systems, or in specific disease indications. The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |